Red X iconGreen tick iconYellow tick icon

Research Fellow

BSc(Hons) (Dundee); MSc (Kent); PhD (Otago)

Tel +64 3 364 3647
Email  alan.aitchison@otago.ac.nz

Dr Aitchison has expertise is in molecular biology and cell biology. Prior to coming to New Zealand, Dr Aitchison worked at Cambridge University, studying epigenetic gene regulation and in the biotech industry studying virology.

Since arriving in Christchurch, he has continued working in molecular biology in a range of settings from psychiatric diseases to leukaemia and, more recently, gut health.

His doctoral studies in Christchurch involved research into the molecular basis of early-onset colorectal cancer with an emphasis on the involvement of gut bacteria in the development of cancer. He is now continuing his interest in gut health by researching how improved nutrition may improve the lives of children with inflammatory bowel disease.

Publications

Leach, S. T., Wheeler, T., Bowcock, N., Aitchison, A., Lemberg, D. A., & Day, A. S. (2026). The emerging roles of intestinal organoid models in inflammatory bowel disease research. Expert Review of Gastroenterology & Hepatology, 20(3), 247-256. doi: 10.1080/17474124.2026.2635421 Journal - Research Other

Aitchison, A., Edwards, T., & Day, A. (2025). Simulated gastrointestinal digestion of bovine A1 β-casein does not increase production of inflammatory proteins in vitro compared to A2 β-casein. Journal of Gastroenterology & Hepatology, 40(Suppl. 1), (pp. 26-27). doi: 10.1111/jgh.16899 Conference Contribution - Published proceedings: Abstract

Aitchison, A., Edwards, T. S., & Day, A. S. (2025). Simulated gastrointestinal digestion of milk caseins containing A1 β-casein does not lead to increased production of inflammatory proteins in intestinal epithelial cells in vitro when compared to milk caseins containing A2 β-casein. Journal of Functional Foods, 125, 106669. doi: 10.1016/j.jff.2025.106669 Journal - Research Article

Keenan, J. I., Aitchison, A., Frizelle, F. A., & Hock, B. D. (2023). Detection of chitinase 3-like 1 in symptomatic primary care patient faecal samples is not a reliable biomarker of colonic lesions. Asian Pacific Journal of Cancer Prevention, 24(7), 2289-2293. doi: 10.31557/APJCP.2023.24.7.2289 Journal - Research Article

Aitchison, A., Pearson, J. F., Purcell, R. V., Frizelle, F. A., & Keenan, J. I. (2022). Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia. PLoS ONE, 17(6), e0269541. doi: 10.1371/journal.pone.0269541 Journal - Research Article

Back to top